|Fastest Growing Market:||Asia Pacific|
|Largest Market:||North America|
Need a report that reflects how COVID-19 has impacted this market and its growth?
The Renal Medical Devices and Services Market is projected to register a CAGR of 6.4% during the forecast period.
The COVID-19 pandemic had affected several departments of the healthcare sector. During the COVID-19 pandemic, various elective surgeries which were termed non-urgent were postponed. This led to a reduction in the healthcare services provided by the hospitals, excluding the COVID treatment. An article titled “Effect of COVID-19 on Kidney Disease Incidence and Management” published in the journal Kidney 360 in January 2021 indicated that in the COVID-19 affected population requiring hospitalization, COVID-19-related acute kidney injury manifested, especially in people requiring intensive care unit (ICU) management. Also, owing to the highly contagious nature of the SARS-CoV-2 virus, people with end-stage kidney disease and kidney transplantation recipients were at increased risk for infection and associated morbidity, especially in light of the underlying immunocompromised state. Thus, the renal medical devices and services market was significantly impacted by the COVID-19 pandemic.
The major factors driving the growth of the renal medical devices and services include the rising prevalence of the kidney diseases, the growing geriatric population and the increasing incidences of daibetes and high blood pressure conditions.
Kidney disease affects a large amount of the global population and has increased in recent decades. It occurs when your kidneys become damaged and can’t perform their function. Damage may be caused by diabetes, high blood pressure, and various other chronic (long-term) conditions. Kidney disease can lead to other health problems, including weak bones, nerve damage, and malnutrition. As per an article by the National Health Portal published in March 2021, there were about 195 million women in the world, who were affected by the kidney diseases as of the date of publication.
Moreover, the geriatric population is more prone to kidney disorders. As the geriatric population is growing, the prevalence of kidney disorders is also expected to increase. According to the report 'World Population Ageing 2020 Highlights' published by the Population division of the United Nations Department of Economic and Social Affairs, there were 727 million people over the age of 65 years in 2020. The report also projected that the number of people over 65 years will reach 1.5 billion by 2050.
As per the United Kingdom Office for National Statistics‘ National Population Projections report published in January 2022, around 1.7 million people over the age of 85 years were living in the United Kingdom in mid-2020, constituting about 2.5% of the total population. The report indicated that the numbers were projected to rise to 3.1 million by mid-2045. Moreover, the Indian Ministry of Statistics and Programme Implementation in its report “Elderly in India 2021” published in July 2021 indicated that around 138 million people over the age of 60 years were living in India in 2021. This population is projected to increase to around 194 million by 2031. The geriatric population are more prone to the loss of bladder control. The onset of various geriatric diseases such as Alzheimers and Parkinson also add to the bladder control problem in the elderly population. The growing older population is expected to further increase the demand for innovative renal disease treatment procedures as aging increases the risk of kidney and bladder problems such as, bladder control issues, and, urinary retention, hence these factors are expected to accelerate the growth of renal medical devices and services market all around the world.
However, reimbursement issues have been dissuading many manufacturers from entering the market. Also, the lack of awareness regarding the presence of such renal disorders treatment in developing and under-developed countries is hindering the market growth.
Scope of the Report
Renal medical devices and services are used to treat or alleviate renal disorders. In the report, a detailed analysis of the renal medical devices and services market is provided. The Renal Medical Devices and Services Market is segmented by Product (Dialysis Equipment, Renal Denervation Devices, Wearable Artificial Kidney Device, and Distal Embolic Protection Devices), Application (Kidney Failure, Chronic Kidney Disease, End-stage Kidney Disease, Renal Kidney Stone Disease, Hypertension, Diabetes, and Others), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The Market report also covers the estimated market sizes and trends of 17 countries across major regions globally. The report offers the value in USD million for the above segments.
|Renal Denervation Devices|
|Wearable Artificial Kidney Device|
|Distal Embolic Protection Devices|
|Chronic Kidney Disease|
|End-stage Kidney Disease|
|Renal Kidney Stone Disease|
Key Market Trends
Renal Kidney Stone Disease is Expected to Register a High CAGR over the Forecast Period.
A kidney stone is a hard, crystalline mineral material formed within the kidney or urinary tract. Kidney stones are a common cause of blood in the urine (hematuria) and often severe pain in the abdomen, flank, or groin. The rising geriatric population and the increasing prevalence of kidney diseases all over the world are expected to add to the growth of the renal kidney stone segment over the forecast period.
An article titled “Kidney Stone Disease: A Brief Review” published in the journal ‘Acta Scientific Pharmacology’ in February 2021 indicated that the incidence of urolithiasis has increased over recent years in developing countries. The article also indicated that around 12% of the Indian population is projected to have kidney stones and that almost 50% of the affected population will end up with renal failure. The large number of people affected by kidney stone diseases, requiring adequate renal medical devices is expected to propel the growth of the studied segment during the forecast period.
Several key market players with their innovative treatments for kidney stone management are expected to propel the growth of the renal medical devices and services market. For instance, in January 2022, Applaud Medical received Food and Drug Administration's breakthrough device designation for its Acoustic Enhancer technology. The Acoustic Enhancer technology is used in conjunction with ureteroscopy with laser lithotripsy for the fragmentation of calcium-based urinary stones. Such product approval is likely to promote segment growth over the forecast period.
To understand key trends, Download Sample Report
North America is Expected to Dominate the Market over the Forecast Period
The North American region is expected to contribute significantly to the market growth during the study period. Factors such as a developed and well-structured health care system, which encourages research and development are expected to add to the growth of the studied market. These research and development policies encourage global players to enter the United States and Canada. As a result, these countries enjoy the presence of many global market players. As high and increasing demand is met by the presence of global players in the region, the market is further expected to increase.
Furthermore, the United States is a major contributor to regional growth owing to factors such as the rising prevalence of kidney diseases and the increasing geriatric population. According to an article titled “Incidence of Kidney Stones in the United States: The Continuous National Health and Nutrition Examination Survey” published in the Journal of Urology in April 2022, the 12-month incidence of kidney stones in the United States population was 2.1% or 2,054 stones per 100,000 adults. The large prevalence of kidney stone disease among the population is expected to propel the growth of the renal medical devices and services market in the North American region over the forecast period.
The rise in the research and development of innovative treatments for renal disorders by various organizations in the United States is also adding to the market growth. For instance, in September 2021, researchers from the University of California San Francisco successfully tested Kidney Project’s implantable bioartificial kidney, which promises to free kidney disease patients from dialysis machines and transplant waiting lists. Such innovations in the renal medical devices segment is expected to boost the growth of the renal medical devices and services market in the North American region over the forecast period.
To understand geography trends, Download Sample Report
The majority of renal medical devices and services are being manufactured by the global key players. Market leaders with more funds for research and better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness. This has also helped the market grow. The real medical devices and services market is competitive and consists of several major and small players. Some of the major market players include B Braun Melsungen AG, Baxter International Inc, Boston Scientific Corporation, Medtronic, Becton, Dickinson and Company, among others.
B Braun Melsungen AG
Baxter International Inc
Boston Scientific Corporation
Becton, Dickinson and Company
- In May 2022, Medtronic and DaVita collaborated to launch a new kidney technology company. The new venture will draw on DaVita’s decades of experience as the leading provider of dialysis services in the United States, as well as Medtronic’s expertise in developing medical technologies across healthcare including in kidney care.
- In January 2022, ReCor Medical, a subsidiary of Otsuka Medical Devices Co. Ltd., launched the Paradise Ultrasound Renal Denervation System for treating uncontrolled hypertension in Germany.
Table of Contents
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidences of Kidney Diseases
4.2.2 Rise in Prevalence of Diabetes and High Blood Pressure Conditions
4.2.3 Growing Geriatric Population
4.3 Market Restraints
4.3.1 Reimbursement Issues
4.3.2 Lack of Awareness in Developing and Under-Developed Regions
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - in USD Millions)
5.1 By Product
5.1.1 Dialysis Equipment
5.1.2 Renal Denervation Devices
5.1.3 Wearable Artificial Kidney Device
5.1.4 Distal Embolic Protection Devices
5.2 By Application
5.2.1 Kidney Failure
5.2.2 Chronic Kidney Disease
5.2.3 End-stage Kidney Disease
5.2.4 Renal Kidney Stone Disease
5.3.1 North America
220.127.116.11 United States
18.104.22.168 United Kingdom
22.214.171.124 Rest of Europe
126.96.36.199 South Korea
188.8.131.52 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
184.108.40.206 South Africa
220.127.116.11 Rest of Middle-East and Africa
5.3.5 South America
18.104.22.168 Rest of South America
6. COMPETITIVE LANDSCAPE
*List Not Exhaustive
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 B Braun Melsungen AG
6.1.3 Baxter International Inc
6.1.4 Becton, Dickinson and Company
6.1.5 Boston Scientific Corporation
6.1.6 DaVita Healthcare Partners, Inc
6.1.7 Fresenius SE & Co. KGaA
6.1.8 Infomed SA
6.1.10 Nipro Corporation
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Frequently Asked Questions
What is the study period of this market?
The Global Renal Medical Devices and Services Market market is studied from 2019 - 2027.
What is the growth rate of Global Renal Medical Devices and Services Market?
The Global Renal Medical Devices and Services Market is growing at a CAGR of 6.4% over the next 5 years.
Which region has highest growth rate in Global Renal Medical Devices and Services Market?
Asia Pacific is growing at the highest CAGR over 2021- 2026.
Which region has largest share in Global Renal Medical Devices and Services Market?
North America holds highest share in 2021.
Who are the key players in Global Renal Medical Devices and Services Market?
B Braun Melsungen AG, Baxter International Inc, Boston Scientific Corporation, Medtronic, Becton, Dickinson and Company are the major companies operating in Global Renal Medical Devices and Services Market.